Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fibrosis × Aspirin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 24 Neoplasms 12 Colonic Neoplasms 12 Breast Neoplasms 12 Prostatic Neoplasms 9 Polycythemia Vera 9 Venous Thromboembolism 8 Multiple Myeloma 8 Recurrence 5 Rectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Thrombocythemia, Essential 4 Ovarian Neoplasms 4 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Myeloproliferative Disorders 4 Barrett Esophagus 4 Precancerous Conditions 3 Melanoma 3 Esophageal Neoplasms 3 Adenomatous Polyps 3 Adenoma 3 Tobacco Use Disorder 2 Thrombosis 2 Thromboembolism 2 Smoking Cessation 2 Sarcoma 2 Primary Myelofibrosis 2 Neoplastic Cells, Circulating 2 Neoplasms by Site 2

Interventions

Magnetic Resonance Spectroscopy 5 Pentoxifylline 4 Liver Transplantation 4 Blood Specimen Collection 4 Specimen Handling 3 High-Energy Shock Waves 3 Tocopherols 2 Sorafenib 2 Simvastatin 2 Low-Level Light Therapy 2 Gemcitabine 2 tremelimumab 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 navitoclax 1 maltodextrin 1 esmolol 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 atezolizumab 1 apixaban 1 alpha-Tocopherol 1 Viusid 1 Vitamin E 1 Vitamin D 1 Tenofovir 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529262 2026-04-14

AspiRe HCC

Curtin University

Phase 3 Not yet recruiting

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡